Usefulness of sweat testing for the detection of MDMA after a single-dose administration

Journal of Analytical Toxicology

Volumn 27, Issue 5, 2003, Pages 294-303

  Pichini, Simona ^a,b   Navarro, Monica ^b   Pacifici, Roberta ^a   Zuccaro, Piergiorgio ^a   Ortuño, Jordi ^b   Farré, Magí ^b,c   Roset, Pere Nolasc ^b,c   Segura, Jordi ^b,d   De la Torre, Rafael ^b,c  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEVICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; DOUBLE BLIND PROCEDURE; DRUG ABUSE; ELUTION; GAS CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; MALE; MASS SPECTROMETRY; METABOLITE; NON INVASIVE MEASUREMENT; RANDOMIZED CONTROLLED TRIAL; STANDARD; SWEAT TEST;

EID: 0037962242     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/27.5.294     Document Type: Article

References (35)

1. H. Zhao, R. Brenneisen, A. Scholer, A. McNally, M.A. Elsohly, T. Murphy, and S.J. Salamone. Profile of urine samples taken from ecstasy users at rave parties: analysis by immunoassays, HPLC, and GC-MS. J. Anal. Toxicol. 25: 258-269 (2001).
2. J.A. Henry, K.J. Jeffreys, and S. Dawling. Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy"). Lancet 340: 384-387 (1992).
3. N. Samyn and C. Van Haeren. On-site testing of saliva and sweat with drugwipe and determination of concentration of drugs of abuse in saliva, plasma and urine of suspected users. Int. J. Legal Med. 113: 150-154 (2000).
4. J. Ortuño, N. Pizarro, M. Farré, M. Mas, J. Segura, J. Camí, R. Breinnessen, and R. de la Torre. Quantification of 3,4-methylenedioxymethamphetamine and its metabolites in plasma and urine by gas chromatography with nitrogen-phosphorus detection. J. Chromatogr. B 723: 221-232 (1999).
5. M. Navarro, S. Pichini, M. Farré, J. Ortuño, P.N. Roset, J. Segura, and R. de la Torre. Usefulness of saliva for measurement of MDMA and its metabolites: correlation with plasma drug concentrations and effect of salivary pH. Clin. Chem. 47: 1788-1795 (2001).
6. C. Jurado, M.P. Gimenez, T. Soriano, M. Menedez, and M. Repetto. Rapid analysis of amphetamine, methamphetamine, MDA, and MDMA in urine using solid-phase microextraction, direct on-fiber derivatization, and analysis by GC-MS. J. Anal. Toxicol. 24: 11-16 (2000).
7. M. Burns and R.C. Baselt. Monitoring drug use with a sweat patch: an experiment with cocaine. J. Anal. Toxicol. 19: 41-48 (1995).
8. D. Kidwell, J. Holland, and S. Athanaselis. Testing for drugs of abuse in saliva and sweat. J. Chromatogr. B 713: 111-135 (1998).
9. W. Schramm, R.H. Smith, P.A. Craig, and D.A. Kidwell. Drugs of abuse in saliva: a review. J. Anal. Toxicol. 16: 1-9 (1992).
10. E.J. Cone. Saliva testing for drugs of abuse. Ann. N.Y. Acad. Sci. 694: 91-127 (1993).
11. K.L. Preston, M.A. Huestis, C.J. Wong, A. Umbricht, B. Goldberger, and E.J. Cone. Monitoring cocaine use in substance-abuse treatment patients with sweat and urine testing. J. Anal. Toxicol. 23: 313-321 (1999).
12. R. Haeckel and P. Hanecke. The application of saliva, sweat and tear fluids for diagnostic purposes. Ann. Biol. Clin. 50: 903-910 (1993).
13. P. Kintz, A. Tracqui, C. Jamey, and P. Mangin. Detection of codeine and phenobarbital in sweat collected with a sweat patch. J. Anal. Toxicol. 20: 197-201 (1996).
14. P. Kintz, A. Tracqui, and P. Mangin. Sweat testing in opioid users with a sweat patch. J. Anal. Toxicol. 20: 393-397 (1996).
15. J. Fay, R. Fogerson, D. Schoendofer, R.S. Niedbala, and V. Spiehler. Detection of metamphetamine in sweat by EIA and GC-MS. J. Anal. Toxicol. 20: 398-403 (1996).
16. R. Fogerson, D. Schoendoffer, J. Fay, and V. Spiehler. Qualitative detection of opiates in sweat by EIA and CG-MS. J. Anal. Toxicol. 21: 451-457 (1997).
17. E.J. Cone, M.J. Hillsgrove, A.J. Jenkins, and R.M. Keenan. Sweat testing for heroin, cocaine and metabolites. J. Anal. Toxicol. 18: 298-305 (1994).
18. P. Kintz, V. Cirimele, and B. Ludes. Codeine testing in sweat and saliva with the drugwipe. Int. J. Legal Med. 111: 81-86 (1997).
19. N. Samyn and C. Van Haeren. On-site testing of saliva and sweat with drugwipe and determination of concentration of drugs of abuse in saliva, plasma and urine of suspected users. Int. J. Legal Med. 113: 150-154 (2000).
20. T.B. Vree, A.T. Muskens, and J.M. Van Rossum. Excretion of amphetamines in human sweat. Arch. Int. Pharmacodyn. Ther. 199: 311-317 (1972).
21. P. Kintz and N. Samyn. Determination of "Ecstasy" components in alternative biologic specimens. J. Chromatogr. B 733: 137-143 (1999).
22. P. Kintz. Excretion of MBDB and BDB in urine, saliva, and sweat following single oral administration. J. Anal. Toxicol. 21: 570-575 (1997).
23. M.A. Huestis, E.J. Cone, C.J. Wong, A. Umbricht, and K.L. Preston. Monitoring opiate use in substance abuse treatment patients with sweat and urine drug testing. J. Anal. Toxicol. 24: 509-521 (2000).
24. R. Pacifici, M. Farré, S. Pichini, J. Ortuño, P.N. Roset, P. Zuccaro, J. Segura, and R. de la Torre. Sweat testing of MDMA with the Drugwipe analytical device: a controlled study with two volunteers. J. Anal. Toxicol. 25: 144-146 (2001).
25. Y. Wang, J. Moss, and R. Thisted. Predictors of body surface area. J. Clin. Anesth. 4: 4-10 (1992).
26. B. Schmid, J. Bircher, R. Preisig, and A. Küpfer. Polymorphic dextromethorphan metabolism: co-segregation of oxidative o-demethylation with debrisoquin hydroxylation. Clin. Pharmacol. Ther. 38: 618-624 (1985).
27. R. de la Torre, M. Farré, P.N. Roset, C. Hernández López, M. Mas, J. Ortuño, E. Menoyo, N. Pizarro, J. Segura, and J. Camí. Pharmacology of MDMA in humans. Ann. N.Y. Acad. Sci. 914: 225-237 (2000).
28. R.C. Baselt, and R.H. Cravey. Disposition of Toxic Drugs and Chemicals in Man, 4th ed. Chemical Toxicology Institute, Foster City, CA, 1995, pp 44 and 475.
29. C. Aly, S.B. Cunico, and H. Mainbach. Effect of prolonged occlusion on the microbial flora, pH, carbon dioxyde and transepidermal water loss on human skin. J. Invest. Dermatol. 71: 378-386 (1978).
30. D.A. Kidwell and F.P. Smith. Susceptibility of PharmCheck™ drugs of abuse patch to environmental contamination. Forensic Sci. Int. 116: 89-106 (2001).
31. P. Kintz, A. Tracqui, and P. Mangin. Sweat testing for benzodiazepines. J. Forensic Sci. 41: 851-854 (1996).
32. J. Camí, M. Farré, M. Mas, P.N. Roset, S. Poudevida, A. Mas, L. San, and R. de la Torre. Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): psychomotor performance and subjective effects. J. Clin. Psychopharmacol. 4: 455-466 (2000).
33. S. Pichini, M. Navarro, M. Farré, J. Ortuño, P.N. Roset, R. Pacifici, P. Zuccaro, J. Segura, and R. de la Torre. On-site testing of 3,4 methylenedioxymethamphetamine (Ecstasy) in saliva with Drugwipe and Drugread: a controlled study in controlled users. Clin. Chem. 48: 174-176 (2002).
34. K. Wolff, A.W.M. Hay, K. Sherlock, and M. Conner. Contents of "ecstasy". Lancet 346: 1100-1101 (1995).
35. M. Baggott, B. Heifets, R.T. Jones, J. Mendelson, E. Sferios, and J. Zehnder. Chemical analysis of ecstasy pills. J. Am. Med. Assoc. 284: 2190 (2000).